Synthetic Biology Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030

Detailed TOC of Synthetic Biology Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Support from Government and Private Institutions
4.2.2 Increasing R&D Investments in Drug Discovery and Development
4.2.3 Declining Cost of DNA Sequencing and Synthesizing
4.3 Market Restraints
4.3.1 Bio-safety and Bio-security
4.3.2 Ethical Issues
4.3.3 Reimbursement Cuts Causing Pricing Pressure
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Core Products
5.1.1.1 Synthetic DNA
5.1.1.2 Synthetic Genes
5.1.1.3 Synthetic Cells
5.1.1.4 XNA (Xeno Nucleic Acid)
5.1.1.5 Chassis Organisms
5.1.2 Enabling Products
5.1.2.1 DNA Synthesis
5.1.2.2 Oligonucleotide Synthesis
5.2 By Technology
5.2.1 Genome Engineering
5.2.2 DNA Sequencing
5.2.3 Bioinformatics
5.2.4 Biological Components and Integrated Systems
5.3 By Applications
5.3.1 Healthcare
5.3.2 Chemicals (Including Bio-Fuels)
5.3.3 Agriculture
5.3.4 Others (Biosecurity, R&D, Energy, and Environment)
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amyris Inc.
6.1.2 E. I. Du Pont De Nemours and Company
6.1.3 Genscript
6.1.4 Integrated DNA Technologies Inc.
6.1.5 Intrexon Corporation
6.1.6 New England Biolabs Inc.
6.1.7 Novozymes A/S
6.1.8 Koninklijke DSM N.V.
6.1.9 Synthetic Genomics Inc.
6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS